[
    [
        {
            "time": "",
            "orginal_text": "泰格医药：预计一季度净利润同比增长1.1倍-1.3倍",
            "features": {
                "keywords": [
                    "泰格医药",
                    "净利润",
                    "同比增长"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "泰格医药：预计一季度净利润同比增长1.1倍-1.3倍",
            "scores": {
                "News_content": "泰格医药：预计一季度净利润同比增长1.1倍-1.3倍",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "orginal_text": "泰格医药：2018年第一季度净利润向下修正为增长110%-130%",
            "features": {
                "keywords": [
                    "泰格医药",
                    "净利润",
                    "向下修正",
                    "增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "泰格医药：2018年第一季度净利润向下修正为增长110%-130%",
            "scores": {
                "News_content": "泰格医药：2018年第一季度净利润向下修正为增长110%-130%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "泰格医药向下修正业绩预告",
            "features": {
                "keywords": [
                    "泰格医药",
                    "业绩预告",
                    "向下修正"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "泰格医药向下修正业绩预告",
            "scores": {
                "News_content": "泰格医药向下修正业绩预告",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[强于大市评级]医药生物行业点评：国务院出台鼓励仿制药文件 国产仿制药迎来春天",
            "features": {
                "keywords": [
                    "仿制药",
                    "政策",
                    "鼓励",
                    "国产"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[强于大市评级]医药生物行业点评：国务院出台鼓励仿制药文件 国产仿制药迎来春天",
            "scores": {
                "News_content": "[强于大市评级]医药生物行业点评：国务院出台鼓励仿制药文件 国产仿制药迎来春天",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药生物行业点评报告：仿制药领域集中受益 一致性评价利好逐步兑现",
            "features": {
                "keywords": [
                    "仿制药",
                    "一致性评价",
                    "利好"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[推荐评级]医药生物行业点评报告：仿制药领域集中受益 一致性评价利好逐步兑现",
            "scores": {
                "News_content": "[推荐评级]医药生物行业点评报告：仿制药领域集中受益 一致性评价利好逐步兑现",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[增持评级]医药生物行业动态：国务院发文促进仿制药研发、生产和使用",
            "features": {
                "keywords": [
                    "仿制药",
                    "研发",
                    "生产",
                    "使用",
                    "政策"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[增持评级]医药生物行业动态：国务院发文促进仿制药研发、生产和使用",
            "scores": {
                "News_content": "[增持评级]医药生物行业动态：国务院发文促进仿制药研发、生产和使用",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "医药生物行业周报：国办出台政策 优质仿制药企长期趋势向好",
            "features": {
                "keywords": [
                    "仿制药",
                    "政策",
                    "长期趋势",
                    "优质"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "医药生物行业周报：国办出台政策 优质仿制药企长期趋势向好",
            "scores": {
                "News_content": "医药生物行业周报：国办出台政策 优质仿制药企长期趋势向好",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 6,
                "Duration": 8,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药行业重点公司2018年一季报业绩前瞻：聚焦一季报 关注创新+升级主线",
            "features": {
                "keywords": [
                    "医药",
                    "一季报",
                    "创新",
                    "升级"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[推荐评级]医药行业重点公司2018年一季报业绩前瞻：聚焦一季报 关注创新+升级主线",
            "scores": {
                "News_content": "[推荐评级]医药行业重点公司2018年一季报业绩前瞻：聚焦一季报 关注创新+升级主线",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "orginal_text": "[看好评级]医药行业事件点评：国务院仿制药政策点评：从仿制药大国走向仿制药强国",
            "features": {
                "keywords": [
                    "仿制药",
                    "政策",
                    "强国"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[看好评级]医药行业事件点评：国务院仿制药政策点评：从仿制药大国走向仿制药强国",
            "scores": {
                "News_content": "[看好评级]医药行业事件点评：国务院仿制药政策点评：从仿制药大国走向仿制药强国",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "[推荐评级]医药行业2018年4月份投资月报暨Q2季度策略：创新+升级 从初春到盛夏",
            "features": {
                "keywords": [
                    "医药",
                    "创新",
                    "升级",
                    "投资策略"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[推荐评级]医药行业2018年4月份投资月报暨Q2季度策略：创新+升级 从初春到盛夏",
            "scores": {
                "News_content": "[推荐评级]医药行业2018年4月份投资月报暨Q2季度策略：创新+升级 从初春到盛夏",
                "Correlation": 4,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "orginal_text": "[买入评级]医药生物行业简评：仿制药产业沐春风 开启强国之路",
            "features": {
                "keywords": [
                    "仿制药",
                    "产业",
                    "春风",
                    "强国"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "[买入评级]医药生物行业简评：仿制药产业沐春风 开启强国之路",
            "scores": {
                "News_content": "[买入评级]医药生物行业简评：仿制药产业沐春风 开启强国之路",
                "Correlation": 5,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "生物医药行业:《关于改革完善仿制药供应保障及使用政策的意见》出台,国内优质仿制药企业受益",
            "features": {
                "keywords": [
                    "仿制药",
                    "政策",
                    "意见",
                    "优质",
                    "受益"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "生物医药行业:《关于改革完善仿制药供应保障及使用政策的意见》出台,国内优质仿制药企业受益",
            "scores": {
                "News_content": "生物医药行业:《关于改革完善仿制药供应保障及使用政策的意见》出台,国内优质仿制药企业受益",
                "Correlation": 6,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]